The U.S. FDA has authorized an emergency coronavirus test that is saliva-based and being funded by the NBA and the NBA Players Association, per Zach Lowe of ESPN.
The test was developed by Yale University and is designed for widespread screening and the cost for consumers could be between $15-$20, which is a significant drop off from the $60-$70 saliva test developed by Rutgers University, which plenty of professional teams are still using.
“(The Yale test) loses a little bit of sensitivity, but what we gain is speed and that it should be up to 10 times cheaper,” Grubaugh said.